beat trend continu support buy
ajg result per share vs forecast consensu beat
project benefit strong result mani key input brokerag post
better expect ep upsid revenu margin organ growth
healthi risk manag ep revenu margin also better
forecast segment result aid somewhat one-tim item look
thru benefit organ growth still better expect loss
corpor segment modestli forecast segment difficult pin
unconcern varianc manag complet acquisit
million annual revenu quarter twice
forecast aid top line go forward
rais estim due overag quarter
maintain forecast howev trend acquisit
activ quarter increas confid model continu assum
modest organ growth brokerag segment second half year
part due tough comparison slight ebitdac margin improv
continu model ebitdac margin risk manag oper
organ growth adjust season clean energi
initi base compani outlook build upon
price object rais reiter buy rate
rais price object reflect modest expans
multipl assumpt po base cash ep
previous confid ajg growth prospect given recent trend
acquisit activ support expand multipl modest premium
compar compani see justifi given ajg better-than-expect
growth opportun driven part success on-going strategi
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
arthur gallagh world fourth-largest
risk manag servic via network
subsidiari place p/c reinsur surplu
line manag employe benefit program
risk manag servic perform
manag loss control consult worker
believ one best-run middle-
market insur broker organ growth
respond better price econom
environ growth along good
expens disciplin allow continu
margin improv acquisit remain
attract avenu growth above-averag
dividend yield attract sustain
trend support thesi
ajg result per share vs forecast consensu beat
project benefit strong result mani key input brokerag post
better expect ep upsid revenu margin organ growth
healthi risk manag ep revenu margin also better
forecast segment result aid somewhat one-tim item look
thru benefit organ growth still better expect loss
corpor segment modestli forecast segment difficult pin
unconcern varianc manag complet acquisit
million annual revenu quarter twice
forecast aid top line go forward
rais estim due overag quarter
maintain forecast howev trend acquisit
activ quarter increas confid model continu assum
modest organ growth brokerag segment second half year
part due tough comparison slight ebitdac margin improv
continu model ebitdac margin risk manag oper
organ growth adjust season clean energi
initi base compani outlook build upon
commiss fee organ growth brokerag segment beat
forecast organ growth volatil quarterli howev base current trend
manag confer call commentari regard market condit
compani initi increas confid forecast look
organ growth line forecast assum
rel modest margin improv believ growth larg come
new busi win good retent rather lift price
econom growth improv price would modest boost better
econom environ would help corpor revenu headcount import
input premium growth assum compani continu activ
risk manag organ growth better expect organ
growth aid million australia may consid non
recur still growth exclud item better expect
expect variabl figur expect mid-to high singl digit growth go
forward expect ebitdac margin run near healthi figur
expect compani abl maintain
acquisit activ remain import
compani close deal second quarter annual revenu
million comfort ahead forecast compani close deal first
quarter annual revenu million full year compani
close deal million acquir annual revenu expect
acquisit continu import contributor growth earn
assum somewhat acceler avenu growth
although assumpt remain histor high valuat ajg target
acquisit remain fairli consist although could rise slightli due tax reform
view sum total ajg results/act favor strateg
financi perspect acquir revenu may consid less valuabl
investor organ growth given natur ajg busi continu
compani ad revenu base acquisit
year view acquir growth favor acquisit continu build
ajg grow global presenc even model new share issu part
 strategi appear accret earn
expect compani continu acquir smaller oper steadi pace
pipelin appear remain quit healthi continu see ajg acquisit
strategi on-going aspect buy rate view growth potenti
bigger platform canada australia uk provid opportun grow
strong track record due dilig integr view smart
acquir believ manag skill resourc effect integr
compani senior manag acquir compani typic remain
compani done effect job due dilig ahead acquisit
ensur cultur strateg fit although intim familiar
busi compani acquir almost smaller privat compani ajg
strong track record provid us confid abil digest
invest incom
gain book sale
chang acquisit earn out/oth
earn incom tax es
provis incom tax es
earn incom tax es
provis incom tax es
organ growth fee
bofa merril lynch global research compani document
estimate
earn incom tax
provis incom tax
invest incom
chang acquisit earn out/oth
earn incom tax
provis incom tax
bofa merril lynch global research compani document
invest incom
chang acquisit earn out/oth
earn incom tax
provis incom tax
earn incom tax
provis incom tax
organ growth fee
earn incom tax
provis incom tax
bofa merril lynch global research compani document
invest incom
chang acquisit earn out/oth
earn incom tax
provis incom tax
bofa merril lynch global research compani document
price object base cash ep modest premium
compar compani see justifi given better-than-expect
growth opportun driven part success on-going strategi downsid
risk price object softer property-casualty price built
expect poor integr one sever acquisit lower industry-wid
claim frequenc hurt claim manag busi rise unemploy
could hurt claim manag busi expos worker
compens residu environment tax liabil relat synthet coal
invest chang health care regul impact benefit broke
busi chang dividend strategi compani
alison jacobowitz herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
